In vitro inhibition of rat platelet aggregation by ochratoxin A.
The mycotoxin ochratoxin A (OA) consists of 5-chloro-3-methyl-3,4-dihydro-8-hydroxyisocoumarin moiety linked by an amide bond to beta-L-phenylalanine. When added to washed rat platelets in vitro, OA caused a dose-dependent inhibition of aggregation induced by agonists such as adenosine diphosphate (ADP) or thrombin. The aggregatory response induced by prior addition of an agonist was also reversed in a dose-dependent manner by OA. Inhibition of aggregation appeared to be irreversible since exposure of platelets to OA followed by several washings removed most of the mycotoxin associated with the platelets but did not diminish the inhibitory response. Serotonin secretion from dense granules and arachidonic acid release from membrane phospholipid (especially phosphatidylcholine) as well as its further metabolism were also inhibited by OA. These results suggest that a disruption of the platelet plasma membrane structure by OA is probably responsible for inhibition of the primary and secondary phases of aggregation.
Omar
R F
RF
Department of Biochemistry, Memorial University of Newfoundland, St. John's, Canada.
Randell
E
E
Rahimtula
A D
AD
D000818:Animals; D016718:Arachidonic Acid / Q000032:analysis / Q000378:metabolism; D066298:In Vitro Techniques; D008297:Male; D009793:Ochratoxins / Q000032:analysis / Q000633:toxicity*; D010974:Platelet Aggregation / Q000187:drug effects*; D010975:Platelet Aggregation Inhibitors / Q000032:analysis / Q000633:toxicity*; D051381:Rats; D011919:Rats, Inbred Strains; D012701:Serotonin / Q000378:metabolism
D009793:Ochratoxins; D010975:Platelet Aggregation Inhibitors; C025589:ochratoxin A; D016718:Arachidonic Acid; D012701:Serotonin